S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)

Cigna - CI Stock Forecast, Price & News

$281.77
0.00 (0.00%)
(As of 08/8/2022 05:24 PM ET)
Add
Compare
Today's Range
$280.73
$283.85
50-Day Range
$242.23
$281.77
52-Week Range
$191.74
$284.46
Volume
2.39 million shs
Average Volume
1.77 million shs
Market Capitalization
$89.40 billion
P/E Ratio
16.80
Dividend Yield
1.59%
Price Target
$294.70

Cigna MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.74 Rating Score
Upside/​Downside
6.7% Upside
$301.55 Price Target
Short Interest
Bearish
2.53% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.19
Upright™ Environmental Score
News Sentiment
0.47mentions of Cigna in the last 14 days
Based on 39 Articles This Week
Insider Trading
Selling Shares
$20.87 M Sold Last Quarter
Proj. Earnings Growth
10.28%
From $22.96 to $25.32 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.64 out of 5 stars

Finance Sector

300th out of 1,207 stocks

Hospital & Medical Service Plans Industry

5th out of 13 stocks

CI stock logo

About Cigna (NYSE:CI) Stock

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Cigna Price Performance

Shares of NYSE:CI traded up $0.44 during trading on Monday, hitting $282.21. The company had a trading volume of 28,754 shares, compared to its average volume of 1,763,850. The company has a market cap of $89.54 billion, a P/E ratio of 16.86, a PEG ratio of 1.11 and a beta of 0.73. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.72 and a current ratio of 0.72. The business's 50-day moving average is $265.57 and its 200 day moving average is $251.77. Cigna has a 52 week low of $191.74 and a 52 week high of $284.46.

Cigna (NYSE:CI - Get Rating) last announced its earnings results on Thursday, August 4th. The health services provider reported $6.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.62 by $0.60. The company had revenue of $45.48 billion for the quarter, compared to analyst estimates of $44.34 billion. Cigna had a return on equity of 15.91% and a net margin of 3.05%. Cigna's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.24 earnings per share. Equities research analysts predict that Cigna will post 22.96 earnings per share for the current fiscal year.

Cigna Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 22nd. Stockholders of record on Wednesday, September 7th will be issued a dividend of $1.12 per share. The ex-dividend date is Tuesday, September 6th. This represents a $4.48 dividend on an annualized basis and a dividend yield of 1.59%. Cigna's dividend payout ratio is currently 26.71%.

Wall Street Analyst Weigh In

CI has been the subject of a number of analyst reports. Stephens boosted their price objective on Cigna from $265.00 to $290.00 and gave the company an "overweight" rating in a research report on Wednesday, April 20th. Mizuho boosted their price target on shares of Cigna from $291.00 to $330.00 and gave the company a "buy" rating in a report on Friday. Raymond James increased their price objective on shares of Cigna from $275.00 to $300.00 in a report on Tuesday, May 10th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Cigna from $236.00 to $284.00 in a research note on Thursday, June 9th. Finally, JPMorgan Chase & Co. upgraded shares of Cigna from a "neutral" rating to an "overweight" rating and raised their price target for the company from $248.00 to $304.00 in a research note on Monday, May 16th. Seven equities research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, Cigna currently has a consensus rating of "Moderate Buy" and a consensus price target of $298.92.

Insider Activity at Cigna

In other Cigna news, CEO David Cordani sold 45,261 shares of the business's stock in a transaction on Tuesday, May 17th. The shares were sold at an average price of $270.42, for a total transaction of $12,239,479.62. Following the sale, the chief executive officer now directly owns 160,499 shares of the company's stock, valued at approximately $43,402,139.58. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CEO David Cordani sold 45,261 shares of the company's stock in a transaction dated Tuesday, May 17th. The stock was sold at an average price of $270.42, for a total value of $12,239,479.62. Following the transaction, the chief executive officer now owns 160,499 shares in the company, valued at approximately $43,402,139.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Nicole S. Jones sold 5,901 shares of the firm's stock in a transaction that occurred on Tuesday, May 17th. The stock was sold at an average price of $270.00, for a total transaction of $1,593,270.00. Following the sale, the executive vice president now owns 36,908 shares of the company's stock, valued at $9,965,160. The disclosure for this sale can be found here. In the last 90 days, insiders sold 76,642 shares of company stock worth $20,869,065. 0.80% of the stock is owned by corporate insiders.

Receive CI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cigna and its competitors with MarketBeat's FREE daily newsletter.

CI Stock News Headlines

Clorox, Hostess fall; MGM, Cigna rise
Stocks that traded heavily or had substantial price changes Thursday: Clorox, Hostess fall; MGM, Cigna rise
Mizuho Increases Cigna (NYSE:CI) Price Target to $330.00
Cigna Co. (NYSE:CI) EVP Sells $247,129.96 in Stock
Cigna Medicare Insurance Review - Benzinga
Company News for Aug 5, 2022
What Are Whales Doing With Cigna - Benzinga
Cigna (CI) Q2 2022 Earnings Call Transcript
Cigna shares up 1.7% premarket after Q2 earnings beat
Cigna (CI) Q2 Earnings and Revenues Beat Estimates
Cigna (CI) Set to Announce Earnings on Thursday
Brokerages Set Cigna Co. (NYSE:CI) Price Target at $290.28
See More Headlines
Receive CI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cigna and its competitors with MarketBeat's FREE daily newsletter.

CI Company Calendar

Ex-Dividend for 6/23 Dividend
6/07/2022
Dividend Payable
6/23/2022
Last Earnings
8/04/2022
Today
8/08/2022
Ex-Dividend for 9/22 Dividend
9/06/2022
Dividend Payable
9/22/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
Sector
Finance
CUSIP
12550910
Employees
73,700
Year Founded
1981

Price Target and Rating

Average Stock Price Forecast
$301.55
High Stock Price Forecast
$330.00
Low Stock Price Forecast
$233.00
Forecasted Upside/Downside
+4.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.74
Research Coverage
22 Analysts

Profitability

Net Income
$5.37 billion
Pretax Margin
3.85%

Debt

Sales & Book Value

Annual Sales
$174.08 billion
Cash Flow
$29.88 per share
Book Value
$142.20 per share

Miscellaneous

Free Float
302,675,000
Market Cap
$89.40 billion
Optionable
Optionable
Beta
0.73

Social Links















CI Stock - Frequently Asked Questions

Should I buy or sell Cigna stock right now?

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cigna in the last twelve months. There are currently 7 hold ratings, 14 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CI shares.
View CI analyst ratings
or view top-rated stocks.

What is Cigna's stock price forecast for 2022?

22 Wall Street research analysts have issued twelve-month target prices for Cigna's shares. Their CI stock forecasts range from $233.00 to $330.00. On average, they expect the company's stock price to reach $301.55 in the next year. This suggests a possible upside of 7.2% from the stock's current price.
View analysts price targets for CI
or view top-rated stocks among Wall Street analysts.

How has Cigna's stock price performed in 2022?

Cigna's stock was trading at $229.63 on January 1st, 2022. Since then, CI shares have increased by 22.5% and is now trading at $281.37.
View the best growth stocks for 2022 here
.

Are investors shorting Cigna?

Cigna saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 7,890,000 shares, an increase of 110.4% from the June 30th total of 3,750,000 shares. Based on an average daily trading volume, of 1,820,000 shares, the short-interest ratio is presently 4.3 days. Currently, 2.5% of the shares of the company are short sold.
View Cigna's Short Interest
.

When is Cigna's next earnings date?

Cigna is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our CI earnings forecast
.

How were Cigna's earnings last quarter?

Cigna Co. (NYSE:CI) posted its earnings results on Thursday, August, 4th. The health services provider reported $6.22 earnings per share for the quarter, topping the consensus estimate of $5.62 by $0.60. The health services provider had revenue of $45.48 billion for the quarter, compared to analysts' expectations of $44.34 billion. Cigna had a trailing twelve-month return on equity of 15.91% and a net margin of 3.05%. The firm's revenue was up 5.4% compared to the same quarter last year. During the same period last year, the firm posted $5.24 earnings per share.
Read the conference call transcript
.

How often does Cigna pay dividends? What is the dividend yield for Cigna?

Cigna declared a quarterly dividend on Wednesday, July 27th. Shareholders of record on Wednesday, September 7th will be given a dividend of $1.12 per share on Thursday, September 22nd. This represents a $4.48 annualized dividend and a dividend yield of 1.59%. The ex-dividend date is Tuesday, September 6th.
Read our dividend analysis for CI
.

Is Cigna a good dividend stock?

Cigna (NYSE:CI) pays an annual dividend of $4.48 per share and currently has a dividend yield of 1.59%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 26.71%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CI will have a dividend payout ratio of 17.69% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CI.

What guidance has Cigna issued on next quarter's earnings?

Cigna updated its FY 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $22.90- for the period, compared to the consensus earnings per share estimate of $22.72. The company issued revenue guidance of $178.00B-, compared to the consensus revenue estimate of $178.59 billion.

What is David Cordani's approval rating as Cigna's CEO?

1,329 employees have rated Cigna Chief Executive Officer David Cordani on Glassdoor.com. David Cordani has an approval rating of 91% among the company's employees. This puts David Cordani in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cigna own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cigna investors own include NVIDIA (NVDA), Walt Disney (DIS), Bank of America (BAC), Salesforce (CRM), Alibaba Group (BABA), CVS Health (CVS), UnitedHealth Group (UNH), Intel (INTC), Johnson & Johnson (JNJ) and Micron Technology (MU).

What is Cigna's stock symbol?

Cigna trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."

Who are Cigna's major shareholders?

Cigna's stock is owned by many different retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.44%), Ruffer LLP (0.35%), Russell Investments Group Ltd. (0.30%), Artemis Investment Management LLP (0.26%), Focused Investors LLC (0.18%) and Victory Capital Management Inc. (0.16%). Insiders that own company stock include David Cordani, Donna F Zarcone, Elder Granger, Eric J Foss, Eric P Palmer, Everett Neville, Jason D Sadler, John M Murabito, John Partridge, Matthew G Manders, Michael W Triplett, Nicole S Jones, Steven B Miller, Timothy C Wentworth and William L Roper.
View institutional ownership trends
.

How do I buy shares of Cigna?

Shares of CI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cigna's stock price today?

One share of CI stock can currently be purchased for approximately $281.37.

How much money does Cigna make?

Cigna (NYSE:CI) has a market capitalization of $89.27 billion and generates $174.08 billion in revenue each year. The health services provider earns $5.37 billion in net income (profit) each year or $16.77 on an earnings per share basis.

How many employees does Cigna have?

Cigna employs 73,700 workers across the globe.

Does Cigna have any subsidiaries?

The following companies are subsidiares of Cigna: Accredo Health Group, Accredo Health Incorporated, Alegis Care, Allegiance Life & Health Insurance Company, Allegiance Re, American Retirement Life Insurance Company, Benefits Management Corp., Bravo Health Mid-Atlantic, Bravo Health Pennsylvania, Brighter, CareAllies, CareCore National LLC, Central Reserve Life Insurance Company, Ceres Sales of Ohio, Choicelinx, Cigna & CMB Life Insurance Company Limited, Cigna Apac Holdings Limited, Cigna Arbor Life Insurance Company, Cigna Beechwood Holdings, Cigna Behavioral Health, Cigna Behavioral Health of California, Cigna Behavioral Health of Texas, Cigna Bellevue Alpha, Cigna Benefits Financing, Cigna Brokerage & Marketing (Thailand) Limited, Cigna Cedar Holdings, Cigna Chestnut Holdings, Cigna Corporate Services, Cigna Data Services (Shanghai) Company Limited, Cigna Dental Health, Cigna Dental Health Plan of Arizona, Cigna Dental Health of California, Cigna Dental Health of Colorado, Cigna Dental Health of Delaware, Cigna Dental Health of Florida, Cigna Dental Health of Illinois, Cigna Dental Health of Kansas, Cigna Dental Health of Kentucky, Cigna Dental Health of Maryland, Cigna Dental Health of Missouri, Cigna Dental Health of New Jersey, Cigna Dental Health of North Carolina, Cigna Dental Health of Ohio, Cigna Dental Health of Pennsylvania, Cigna Dental Health of Texas, Cigna Dental Health of Virginia, Cigna Elmwood Holdings, Cigna Europe Insurance Company S.A.-N.V., Cigna European Services (UK) Limited, Cigna Finans Emeklilik ve Hayat A.S., Cigna Global Holdings, Cigna Global Insurance Company Limited, Cigna Global Reinsurance Company, Cigna Global Wellbeing Holdings Limited, Cigna Global Wellbeing Solutions Limited, Cigna HLA Technology Services Company Limited, Cigna Health Corporation, Cigna Health Management, Cigna Health Solutions India Pvt. Ltd., Cigna Health and Life Insurance Company, Cigna HealthSpring, Cigna Healthcare Holdings, Cigna Healthcare Mid-Atlantic, Cigna Healthcare of Arizona, Cigna Healthcare of California, Cigna Healthcare of Colorado, Cigna Healthcare of Connecticut, Cigna Healthcare of Florida, Cigna Healthcare of Georgia, Cigna Healthcare of Illinois, Cigna Healthcare of Indiana, Cigna Healthcare of Maine, Cigna Healthcare of Massachusetts, Cigna Healthcare of New Hampshire, Cigna Healthcare of New Jersey, Cigna Healthcare of North Carolina, Cigna Healthcare of Pennsylvania, Cigna Healthcare of South Carolina, Cigna Healthcare of St. Louis, Cigna Healthcare of Tennessee, Cigna Healthcare of Texas, Cigna Healthcare of Utah, Cigna Holding Company, Cigna Holdings, Cigna Holdings Overseas, Cigna Hong Kong Holdings Company Limited, Cigna Insurance Middle East S.A., Cigna Insurance Public Company Limited, Cigna Insurance Services (Europe) Limited, Cigna Intellectual Property, Cigna International Corporation, Cigna International Health Services, Cigna International Health Services BVBA, Cigna International Health Services Kenya Limited, Cigna International Health Services SDN BHD, Cigna International Services, Cigna International Services Australia Pty. Ltd., Cigna Investment Group, Cigna Investments, Cigna Korean Chusik Hoesa, Cigna Laurel Holdings, Cigna Legal Protection UK Ltd., Cigna Life Insurance Company of Canada, Cigna Life Insurance Company of Europe S.A.- N.V., Cigna Life Insurance Company of New York, Cigna Life Insurance New Zealand Limited, Cigna Linden Holdings, Cigna Magnolia Holdings, Cigna Myrtle Holdings, Cigna Nederland Alpha Cooperatief U.A., Cigna Nederland Beta B.V., Cigna Nederland Gamma B.V., Cigna Oak Holdings, Cigna Palmetto Holdings, Cigna Poplar Holdings, Cigna Sequoia Holdings, Cigna Spruce Holdings GmbH, Cigna Taiwan Life Assurance Company Limited, Cigna Walnut Holdings, Cigna Willow Holdings, Cigna Worldwide General Insurance Company Limited, Cigna Worldwide Insurance Company, Cigna Worldwide Life Insurance Company Limited, CignaTTK Health Insurance Company Limited, Connecticut General Corporation, Connecticut General Life Insurance Company, CuraScript Inc., E-2 CIGNA CORPORATION - 2018 Form 10-K, ESI Mail Pharmacy Service Inc., ESI Partnership, ESI Resources Inc., Express Scripts Holding Company, Express Scripts Inc., Express Scripts Pharmaceutical LLC, Express Scripts Pharmacy Inc., Express Scripts Strategic Development Inc., FirstAssist Administration Limited, Firstassist Insurance Services Ltd, Great-West Healthcare of Illinois, Grown Ups New Zealand Limited, Health-Lynx LLC, HealthSource, HealthSpring, HealthSpring Life & Health Insurance Company, HealthSpring of Alabama, HealthSpring of Florida, HealthSpring of Tennessee, KDM Thailand Limited, LINA Financial Services, LINA Life Insurance Company of Korea, Life Insurance Company of North America, Loyal American Life Insurance Company, MCC Independent Practice Association of New York, Manipal Cigna Health Insurance Company Limited, Medco Containment Life Insurance Company, Medco Health Services Inc., Medco Health Solutions Inc., NewQuest, NewQuest Management Northeast, Olympic Health Management Services, Oz Parent, PT Asuransi Cigna, Provident American Life and Health Insurance Company, Qualcare, Qualcare Alliance Networks, Qualcare Captive Insurance Company Inc. PCC, Qualcare Management Resources Limited Liability Company, RHP (Thailand) Limited, Scibal Associates, Sterling Life Insurance Company, Tel-Drug, Tel-Drug of Pennsylvania, Temple Insurance Company Limited, United Benefit Life Insurance Company, Verity Solutions Group, Zurich Insurance Middle East, and eviCore 1 LLC.
Read More

When was Cigna founded?

Cigna was founded in 1981.

How can I contact Cigna?

Cigna's mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The official website for the company is www.cigna.com. The health services provider can be reached via phone at (860) 226-6000, via email at william.mcdowell2@cigna.com, or via fax at 860-226-6741.

This page (NYSE:CI) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.